These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39087624)

  • 1. An ultra-fast ultra-high-performance liquid chromatography-tandem mass spectrometry method for estimating the in vitro metabolic stability of palbociclib in human liver microsomes: In silico study for metabolic lability, absorption, distribution, metabolism, and excretion features, and DEREK alerts screening.
    Attwa MW; Abdelhameed AS; Kadi AA
    J Sep Sci; 2024 Aug; 47(15):e2400346. PubMed ID: 39087624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-fast UPLC-MS/MS approach for estimating X-376 in human liver microsomes: Evaluation of metabolic stability via in silico software and in vitro analysis.
    Attwa MW; Abdelhameed AS; Kadi AA
    J Pharmacol Toxicol Methods; 2024; 128():107540. PubMed ID: 38996943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ultra-fast green ultra-high-performance liquid chromatography-tandem mass spectrometry method for estimating the in vitro metabolic stability of zotizalkib in human liver microsomes.
    Attwa MW; Abdelhameed AS; Kadi AA
    J Sep Sci; 2024 Aug; 47(15):e2400393. PubMed ID: 39087620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites.
    Chavan BB; Tiwari S; G S; Nimbalkar RD; Garg P; R S; Talluri MVNK
    J Pharm Biomed Anal; 2018 Aug; 157():59-74. PubMed ID: 29772457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Validated LC-MS/MS Assay for the Simultaneous Quantification of the FDA-Approved Anticancer Mixture (Encorafenib and Binimetinib): Metabolic Stability Estimation.
    Attwa MW; Darwish HW; Al-Shakliah NS; Kadi AA
    Molecules; 2021 May; 26(9):. PubMed ID: 34063139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies.
    Attwa MW; Kadi AA; Abdelhameed AS; Alhazmi HA
    Drug Des Devel Ther; 2020; 14():783-793. PubMed ID: 32158196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay.
    Attwa MW; Abdelhameed AS; Al-Shakliah NS; Kadi AA
    Drug Des Devel Ther; 2020; 14():4439-4449. PubMed ID: 33122888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes.
    Attwa MW; AlRabiah H; Kadi AA
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of zorifertinib metabolic stability in human liver microsomes using LC-MS/MS.
    Attwa MW; Al-Shakliah NS; AlRabiah H; Kadi AA; Abdelhameed AS
    J Pharm Biomed Anal; 2022 Mar; 211():114626. PubMed ID: 35123331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the
    Attwa MW; AlRabiah H; Abdelhameed AS; Kadi AA
    Front Chem; 2024; 12():1323738. PubMed ID: 39391832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation.
    Attwa MW; Abdelhameed AS; Kadi AA
    Drug Des Devel Ther; 2021; 15():3915-3925. PubMed ID: 34552321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method.
    Attwa MW; AlRabiah H; Mostafa GAE; Bakheit AH; Kadi AA
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening.
    Attwa MW; AlRabiah H; Mostafa GAE; Kadi AA
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software.
    Attwa MW; Abdelhameed AS; Kadi AA
    Heliyon; 2024 Jul; 10(13):e34109. PubMed ID: 39091946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation.
    Attwa MW; AlRabiah H; Mostafa GAE; Kadi AA
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An available strategy based on accurate mass by ultra high performance liquid chromatography coupled to Fourier transform ion cyclotron resonance mass spectrometry technology to characterization of metabolic profile of palbociclib in rat urine, feces and bile.
    Yao J; Jiang X; Liu Q; Yuan X; Feng T; Li K; Zhao L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():37-46. PubMed ID: 31176268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Ultrafast UPLC-MS/MS Method for Characterizing the In Vitro Metabolic Stability of Acalabrutinib.
    Attwa MW; Bakheit AH; Abdelhameed AS; Kadi AA
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes.
    Mostafa GAE; Kadi AA; AlMasoud N; Attwa MW; Al-Shakliah NS; AlRabiah H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122806. PubMed ID: 34325312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the irreversible fibroblast growth factor receptor inhibitor futibatinib by UPLC-MS/MS: Application to the metabolic stability assay in human liver microsomes for the estimation of its in vitro hepatic intrinsic clearance.
    Tang LWT; Chan ECY
    J Pharm Biomed Anal; 2022 May; 214():114731. PubMed ID: 35325798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an HPLC-MS/MS method for the determination of filgotinib, a selective Janus kinase 1 inhibitor: Application to a metabolic stability study.
    AlRabiah H; Kadi AA; Attwa MW; Mostafa GAE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1154():122195. PubMed ID: 32943176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.